Related Experiment Videos
The zinc-immunodeficiency relationship in old patients
S Bădulici1, M Chirilă, M Cojocaru
1Christiana Center of Social Medicine, Bucharest.
Summary
Oral zinc sulfate therapy impacts humoral immunity by lowering immunoglobulin levels, particularly IgG, in older adults. This suggests zinc plays a role in regulating immune responses.
Area of Science:
- Immunology
- Nutritional Science
- Gerontology
Background:
- Humoral immunity involves antibody production by B cells.
- Immunoglobulins (Ig), especially IgG, are key components of humoral immunity.
- Zinc is an essential trace element involved in numerous biological processes, including immune function.
Purpose of the Study:
- To investigate the effect of oral zinc sulfate on humoral immunity in elderly patients.
- To assess changes in serum immunoglobulin levels and plasma zinc concentrations.
- To compare the effects of zinc therapy with placebo and healthy controls.
Main Methods:
- A double-blind study involving 12 elderly patients receiving zinc sulfate, 11 receiving placebo, and 50 healthy controls.
- Measurement of serum immunoglobulin (Ig) levels, including IgG class.
- Quantification of plasma zinc levels.
Main Results:
- Zinc sulfate therapy led to a statistically significant reduction in initially high immunoglobulin levels.
- The decrease was particularly notable in the IgG class.
- Plasma zinc levels were likely monitored to confirm absorption and correlate with immune changes.
Conclusions:
- Oral zinc sulfate therapy demonstrates a significant effect on immunoregulation in elderly individuals.
- Zinc supplementation can modulate humoral immunity, specifically reducing elevated immunoglobulin levels.
- Further clinical trials are warranted to explore optimal zinc concentrations for immune modulation.